Home » Topics » Dermatologic, BioWorld Science

Dermatologic, BioWorld Science
RSS

Aclaris Therapeutics starts phase III trials for A-101 in seborrheic keratosis

Jan. 20, 2016

Topical quinolone antibacterial Zebiax launched in Japan

Jan. 12, 2016

Anacor submits NDA for crisaborole for atopic dermatitis

Jan. 8, 2016

Genetic association meta-analysis identifies 10 novel risk loci for atopic dermatitis

Jan. 8, 2016

Vitae initiates proof-of-concept study of VTP-38543 in atopic dermatitis

Dec. 30, 2015

Amarantus requests rare pediatric disease and orphan drug designations

Dec. 30, 2015

Revance's RT-001 reduces sweating in phase II axillary hyperhidrosis study

Dec. 28, 2015

AntibioTx advances preclinical development of dermal formulation of ATx-201

Dec. 23, 2015

Brickell Biotech reports data from phase IIb BBI-4000 trial in hyperhidrosis

Dec. 22, 2015

FDA grants orphan drug designation to cromolyn sodium (inhaled) for mastocytosis

Dec. 15, 2015

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 28, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
Brain-penetrant NLRP3 inhibitor shows promise in Parkinson’s
BioWorld Science
Researchers from Changchun Genescience Pharmaceuticals Co. Ltd. described the discovery and preclinical profile of an NLRP3 inhibitor with favorable brain...
Daybu readthrough in EU? Zevra’s NPC bid flounders
BioWorld
Zevra Therapeutics Inc. will try to follow in the footsteps of Acadia Pharmaceuticals Inc. with Rett syndrome drug Daybu (trofinetide) by asking the EMA’s...
Transcripta Bio raises funding to advance neuro pipeline
BioWorld Science
Transcripta Bio Inc. has raised $24 million since its series A to fund IND-enabling studies across its portfolio and support clinical preparation in its autism...